Individualized therapies for treating type 2 diabetes recommended
April 04, 2016
Other researchers working on the consensus statement include David Nathan of Harvard Medical School in Boston, Mass.; Silva Arslanian of the University of Pittsburgh School of Medicine in Penn.; Leif Groop of Lund University in Malmo, Sweden; Robert Rizza of the Mayo Clinic in Rochester, Minn.; and Jerome Rotter of Cedars-Sinai Medical Center in Los Angeles, Calif.
The statement, "Individualizing Therapies in Type 2 Diabetes Mellitus Based on Patient Characteristics: What We Know and What We Need to Know," will appear in the April 2010 issue of JCEM.
Source: The Endocrine Society